WILLIAM WILSON: Open Payments
NPI 1295223873 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 96 payments from 15 companies in 2025. Trend: 2023 $917 · 2024 $757 · 2025 $1,719
Food & beverage: $1,646Education: $73
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $279 |
| Otsuka America Pharmaceutical, Inc. | 27 | $270 |
| Corium, LLC | 7 | $206 |
| Supernus Pharmaceuticals, Inc. | 12 | $203 |
| Neurocrine BioSciences, Inc. | 6 | $146 |
| Janssen Pharmaceuticals, Inc | 7 | $137 |
| Alkermes, Inc. | 5 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Lundbeck LLC | 4 | $79 |
Products named: Azstarys, Qelbree, REXULTI, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across TN — which companies pay providers there.
